Rituximab and antineutrophil cytoplasmic antibody-associated vasculitis: granulomatous disease more resistant than vasculitis disease?
- PMID: 18391671
- DOI: 10.1097/RHU.0b013e31816b449e
Rituximab and antineutrophil cytoplasmic antibody-associated vasculitis: granulomatous disease more resistant than vasculitis disease?
Comment on
-
Effect of rituximab on refractory Wegener granulomatosis with predominant granulomatous disease.J Clin Rheumatol. 2008 Apr;14(2):92-3. doi: 10.1097/RHU.0b013e31816b4487. J Clin Rheumatol. 2008. PMID: 18391678
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
